![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000042944 |
Receipt No. | R000048562 |
Scientific Title | The immunological analyses of human peripheral blood mononuclear cells. |
Date of disclosure of the study information | 2021/01/10 |
Last modified on | 2021/01/08 |
Basic information | ||
Public title | The immunological analyses of human blood cells. | |
Acronym | The analyses of human blood cells. | |
Scientific Title | The immunological analyses of human peripheral blood mononuclear cells. | |
Scientific Title:Acronym | The analyses of human peripheral blood mononuclear cells. | |
Region |
|
Condition | ||
Condition | Healthy donners | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | This study is to investigate the immune response of human peripheral blood mononuclear cells. Cells are subjected to protein expression analyses, gene expression analyses, epigenetic analyses, and in vitro culture experiments. |
Basic objectives2 | Others |
Basic objectives -Others | Immunology research |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | The analyses of gene expression, protein expression, and epigenetic modifications. |
Key secondary outcomes |
Base | |
Study type | Observational |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Persons who do not have any diseases which require treatments. | |||
Key exclusion criteria | Persons who have diseases.
Persons who drowned blood within two weeks. Persons who do not agree with this study. |
|||
Target sample size | 60 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Chiba University Graduate School of Medicine | ||||||
Division name | Department of Allergy and Clinical Immunology | ||||||
Zip code | 260-8670 | ||||||
Address | 1-8-1 Inohoana, Chuo-ku, Chiba, Chiba | ||||||
TEL | 043-226-2198 | ||||||
nakajimh@faculty.chiba-u.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Chiba University Graduate School of Medicine | ||||||
Division name | Department of Allergy and Clinical Immunology | ||||||
Zip code | 260-8670 | ||||||
Address | 1-8-1 Inohoana, Chuo-ku, Chiba, Chiba | ||||||
TEL | 043-226-2198 | ||||||
Homepage URL | |||||||
stanaka@chiba-u.jp |
Sponsor | |
Institute | Chiba University |
Institute | |
Department |
Funding Source | |
Organization | Ministray of Education, Culture, Sports, Science and Technology |
Organization | |
Division | |
Category of Funding Organization | Japanese Governmental office |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Chiba University Graduate School of Medicine, Ethics Committe |
Address | 1-8-1 Inohoana, Chuo-ku, Chiba, Chiba |
Tel | 043-226-2462 |
inohana-rinri@chiba-u.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | this study aim to analyze PBMC from healthy donners. |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048562 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |